Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Other 1

Conditions

Endometrial Neoplasms 3Overweight 1Obesity 1Infertility 1Endometrial Hyperplasia 1

Interventions

Magnetic Resonance Spectroscopy 84Specimen Handling 83Cyclophosphamide 75pembrolizumab 64Radiotherapy 54Nivolumab 52fludarabine 44Cisplatin 40Biopsy 40Carboplatin 39Standard of Care 38Bevacizumab 32Dexamethasone 31Rituximab 29Gemcitabine 29venetoclax 27Surveys and Questionnaires 27Radiosurgery 27Radiation 27Temozolomide 26Practice Guidelines as Topic 26Paclitaxel 25Doxorubicin 25Blood Specimen Collection 25Cytarabine 24fludarabine phosphate 23Interviews as Topic 22atezolizumab 21Injections 20Capecitabine 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Megestrol Acetate × 30 days × Clear all
NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Fudan University

Phase 2 Recruiting
104 enrolled
Gynecologic

Endometrial Neoplasms

NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT03671811 2026-06-03

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

City of Hope Medical Center

Phase 2 Active not recruiting
44 enrolled 12 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡